MetLife Investment Advisors »

Supernus Pharmaceuticals shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $753k 26k 28.94
2023-09-30 $717k 26k 27.57
2023-06-30 $782k 26k 30.06
2023-03-31 $942k 26k 36.23
2022-12-31 $928k 26k 35.67
2022-09-30 $909k 27k 33.87
2022-06-30 $806k 28k 28.92
2022-03-31 $901k 28k 32.32
2021-12-31 $525k 18k 29.16
2021-09-30 $480k 18k 26.67
2021-06-30 $554k 18k 30.79
2021-03-31 $589k 23k 26.18
2020-12-31 $566k 23k 25.16
2020-09-30 $469k 23k 20.84
2020-06-30 $534k 23k 23.74
2020-03-31 $405k 23k 17.99
2019-12-31 $534k 23k 23.72
2019-09-30 $618k 23k 27.48
2019-06-30 $744k 23k 33.08
2019-03-31 $788k 23k 35.04
2018-12-31 $747k 23k 33.22
2018-09-30 $1.8M 35k 50.35
2018-06-30 $1.3M 23k 59.84
2018-03-31 $983k 22k 45.78
2017-12-31 $856k 22k 39.87